| Financial Year |
March 31 2023 |
| Monetary Funds |
284,771,046.83 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
272,074,268.99 |
| Advances to Suppliers |
86,669,749.11 |
| Other Receivables |
84,787,410.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
427,973,573.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
60,829,370.65 |
| Total Current Assets |
1,244,244,968.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,888,347,734.32 |
| Investment Properties |
112,770,977.97 |
| Fixed Assetes |
2,203,727,630.58 |
| Under-construction Projects |
294,431,429.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
679,871,800.27 |
| R&D expenses |
112,144,119.98 |
| Goodwill |
38,198,824.53 |
| Long-Term Deferred and Prepaid Expenses |
17,072,572.62 |
| Deferred Income Tax Assets |
41,654,708.26 |
| Other Non-Current Assets |
2,807,044.57 |
| Sub-Total of Non-Current Assets |
5,912,351,623.28 |
| Total Assets |
7,156,596,591.90 |
| Short-Term Loans |
200,178,750.00 |
| Trading Financial liabilities |
407,740.00 |
| Notes Payable |
-- |
| Accounts Payable |
558,026,544.38 |
| Accounts Received In Advance |
2,110,908.66 |
| Employee Compensation Payable |
17,437,466.03 |
| Taxes Payable |
58,919,501.75 |
| Interest Payable |
-- |
| Dividend Payable |
16,466,174.82 |
| Other payables |
220,641,541.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
251,319,333.35 |
| Other Current Liabilities |
9,366,837.43 |
| Sub-Total of Current Liabilities |
1,405,215,540.22 |
| Long-term Loans |
24,024,200.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
15,806,733.47 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,966,686.06 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
166,431,833.72 |
| Total Liabilities |
1,571,647,373.94 |
| Paid-In Capital(Or Share Stock) |
344,083,828.00 |
| Capital Surplus |
490,056,872.92 |
| Surplus Reserve |
330,263,564.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,145,807,319.57 |
| Minority Stockholder's Interest |
378,804,213.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,206,145,004.22 |
| Owner's Equity（Stockholder's Equity） |
5,584,949,217.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,156,596,591.90 |
